Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDoxorubicinCyclophosphamideOsteosarcomaCombined Modality TherapyCisplatinDisease-Free SurvivalVincristineTreatment OutcomeChemotherapy, AdjuvantPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesClinical ProtocolsAntibiotics, AntineoplasticAntineoplastic Agents, PhytogenicEtoposideBreast NeoplasmsNeoplasmsNeoadjuvant TherapyAntineoplastic Agents, AlkylatingDrug Administration SchedulePaclitaxelAntimetabolites, AntineoplasticLung NeoplasmsMethotrexateSurvival AnalysisNeoplasm StagingSurvival RateDrug Resistance, NeoplasmVinblastineCarboplatinBleomycinTime FactorsTaxoidsCell Line, TumorIfosfamideCytarabineOrganoplatinum CompoundsInduction ChemotherapyDrug Screening Assays, AntitumorDose-Response Relationship, DrugDeoxycytidineNeoplasm Recurrence, LocalAnthracyclinesApoptosisOvarian NeoplasmsDaunorubicinClinical Trials as TopicNeoplasm MetastasisCarmustineFollow-Up StudiesAdenocarcinomaCarcinoma, Non-Small-Cell LungVomitingTumor Cells, CulturedNauseaCamptothecinDrug SynergismLymphoma, Non-HodgkinColorectal NeoplasmsNeutropeniaChemotherapy, Cancer, Regional PerfusionSalvage TherapyLomustineCell SurvivalMitomycinRadiotherapyBrain NeoplasmsProspective StudiesDacarbazineInfusions, IntravenousMelphalanTransplantation, AutologousBone NeoplasmsTesticular NeoplasmsLeukopeniaRadiotherapy, AdjuvantLeukemia P388MitoxantroneHodgkin DiseaseXenograft Model Antitumor AssaysDrug EvaluationAntineoplastic ProtocolsLiver NeoplasmsAntibodies, Monoclonal, Humanized6-MercaptopurineLymphomaGalliumRandomized Controlled Trials as TopicColonic NeoplasmsTumor Markers, BiologicalCarcinoma, Squamous CellKaplan-Meier EstimateCell ProliferationNeoplasms, Germ Cell and EmbryonalCarcinomaBryostatinsEllipticines